Marketing-authorisation holder
Natco Pharma Limited
29 medicines in 2 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder
29 medicines in 2 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 29
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ALPRAZOLAM0.25mg | 0.5mg | 1mg | 2mg · Tablet | Alprazolam | United States | Marketed | 1993 |
| ARMODAFINIL100mg | 150mg | 200mg | 2500mg | 250mg | 50mg · Tablet | Armodafinil | United States | Marketed | 2012 |
| AZACITIDINE100mg/vial · Powder | Azacitidine | United States | Marketed | 2013 |
| BOSENTAN32mg · Tablet, for suspension | Bosentan | United States | Marketed | 2025 |
| CARISOPRODOL250mg | 350mg · Tablet | Carisoprodol | United States | Marketed | 1979 |
| CLORPRES15mg; 0.1mg | 15mg; 0.2mg | 15mg; 0.3mg · Tablet | Chlorthalidone, Clonidine | United States | Not marketed | 1987 |
| ETODOLAC200mg | 300mg · Capsule | Etodolac | United States | Marketed | 1997 |
| EVEROLIMUS2mg | 3mg | 5mg · Tablet, for suspension | Everolimus | United States | Marketed | 2019 |
| GEMFIBROZIL300mg · Capsule | Gemfibrozil | United States | Not marketed | 1991 |
| GLYCOPYRROLATE1.5mg | 1mg | 2mg · Tablet | Glycopyrronium | United States | Marketed | 1981 |
| IDELALISIB100mg | 150mg · Tablet | Idelalisib | United States | Marketed | 2026 |
| IMATINIB MESYLATE100mg base | 400mg base · Tablet | Imatinib | United States | Marketed | 2015 |
| LANTHANUM CARBONATE1gm base | 500mg base | 750mg base · Tablet, chewable | Lanthanum carbonate | United States | Marketed | 2017 |
| LAPATINIB DITOSYLATE250mg base · Tablet | Lapatinib ditosylate | United States | Marketed | 2020 |
| NADOLOL AND BENDROFLUMETHIAZIDE5mg; 40mg | 5mg; 80mg · Tablet | Bendroflumethiazide, Nadolol | United States | Not marketed | 2007 |
| RAMIPRIL1.25mg | 10mg | 2.5mg | 5mg · Tablet | Ramipril | United States | Not marketed | 2009 |
| RIZATRIPTAN BENZOATE10mg base | 5mg base · Tablet | Rizatriptan | United States | Marketed | 2012 |
| THALIDOMIDE100mg | 150mg | 200mg | 50mg · Capsule | Thalidomide | United States | Marketed | 2023 |
| TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE6.14mg base; 15mg | 8.19mg base; 20mg · Tablet | Tipiracil, Trifluridine | United States | Marketed | 2023 |
| Apixaban BOS | Apixaban | Saudi Arabia | Authorised | |
| Deroxi Liposomal 50 mg per 25 ml | Doxorubicin | Saudi Arabia | Authorised | |
| Incell | Ibrutinib | Saudi Arabia | Authorised | |
| Lenalidomide BOS | Lenalidomide | Saudi Arabia | Authorised | |
| MAVEC 100MG F.C. TABLET | Imatinib | Saudi Arabia | Authorised | |
| MAVEC 400MG F.C. TABLET | Imatinib | Saudi Arabia | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 21 | 19 | 2 | CompaniesAll medicines |
| Saudi Arabia | 8 | 8 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.